Challenges in Assessing the Process–Outcome Link in Practice
暂无分享,去创建一个
[1] John Holden,et al. Vaccines for preventing pneumococcal infection in adults. , 2013, The Cochrane database of systematic reviews.
[2] E John Orav,et al. The long-term effect of premier pay for performance on patient outcomes. , 2012, The New England journal of medicine.
[3] A. Ryan,et al. Medicare's public reporting initiative on hospital quality had modest or no impact on mortality from three key conditions. , 2012, Health affairs.
[4] Onyebuchi A Arah,et al. Bias Formulas for Sensitivity Analysis of Unmeasured Confounding for General Outcomes, Treatments, and Confounders , 2011, Epidemiology.
[5] T. Pruett. Adherence to Surgical Care Improvement Project Measures and the Association With Postoperative Infections , 2011 .
[6] Lee A Fleisher,et al. Association of surgical care improvement project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement. , 2010, Journal of the American College of Surgeons.
[7] Karla Hemming,et al. Evaluating policy and service interventions: framework to guide selection and interpretation of study end points , 2010, BMJ : British Medical Journal.
[8] Eric T. Bradlow,et al. Public reporting on hospital process improvements is linked to better patient outcomes. , 2010, Health affairs.
[9] E. Stuart,et al. Impact of public reporting on quality of postacute care. , 2009, Health services research.
[10] Tim Doran,et al. Exclusion of patients from pay-for-performance targets by English physicians. , 2008, The New England journal of medicine.
[11] Eric T. Bradlow,et al. Relationship between Medicare's hospital compare performance measures and mortality rates. , 2006, JAMA.
[12] K. Anstrom,et al. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. , 2006, American heart journal.
[13] F. McAlister,et al. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. , 2002, The American journal of medicine.
[14] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[15] L. Alley,et al. Application of HEDIS measures within a Veterans Affairs medical center. , 2000, The American journal of managed care.
[16] Nick Freemantle,et al. β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .
[17] N Freemantle,et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.
[18] R. Kronmal,et al. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. , 1998, Biometrics.
[19] S Greenland,et al. Basic methods for sensitivity analysis of biases. , 1996, International journal of epidemiology.
[20] J. Iglehart,et al. The National Committee for Quality Assurance. , 1996, The New England journal of medicine.
[21] Jonathan Mant,et al. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction , 1995, BMJ.
[22] D. Warner,et al. Statistical power, sample size, and their reporting in randomized controlled trials , 1995 .
[23] F. Klocke,et al. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag , 1990, Circulation.
[24] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[25] Furberg Cd,et al. The beta‐blocker heart attack trial. , 1982 .
[26] K. Swedberg,et al. EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.